Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Resectable NSCLC × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6797 Lung Neoplasms 5041 Small Cell Lung Carcinoma 1145 Breast Neoplasms 846 Neoplasms 760 Colorectal Neoplasms 654 Melanoma 560 Ovarian Neoplasms 502 Neoplasm Metastasis 477 Pancreatic Neoplasms 466 Adenocarcinoma of Lung 396 Stomach Neoplasms 393 Prostatic Neoplasms 369 Head and Neck Neoplasms 361 Carcinoma, Renal Cell 344 Esophageal Neoplasms 333 Mesothelioma, Malignant 322 Squamous Cell Carcinoma of Head and Neck 320 Colonic Neoplasms 292 Mesothelioma 287 Urinary Bladder Neoplasms 262 Brain Neoplasms 252 Uterine Cervical Neoplasms 238 Triple Negative Breast Neoplasms 218 Sarcoma 196 Endometrial Neoplasms 192 Carcinoma, Hepatocellular 182 NSCLC 164 Pleural Effusion, Malignant 159 Kidney Neoplasms 159

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07492342 2026-03-25

K-NADIR

The First Affiliated Hospital of Guangzhou Medical University

Phase 2 Recruiting

Resectable NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡